17 Apr 2008 - Servier decided to install Definiens technology in its two core Discovery Research facilities located in Suresnes and Croissy-sur-Seine. Preceded by several successful test projects, this strategic decision was made internally in fall 2007. Servier expects that the enterprise-wide integration of Definiens image analysis software will play a key role within the organization's various research departments. According to the company, Definiens offers a clear advantage for pharmaceutical companies because its software automates image analysis processes and leads to more objective results compared to manual approaches.
Brian Lockhart, Director of Servier's Division Molecular Pharmacology and Pathophysiology: "In order to put molecular histopathology at the core of Servier's drug discovery programs, the decision to integrate Definiens' innovative and robust Definiens Enterprise Image Intelligence(TM) Suite is a critical step in the success of this strategy."
 |
www.bionity.com/news/e/80870 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/80870 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |